Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2021)
Insight Molecular Diagnostics' (IMDX) quarterly Tax Provisions came in at -$97000.0 in Q4 2021, down 161.01% year-on-year from $159000.0 in Q4 2020, and up 94.59% quarter-over-quarter from -$1.8 million in Q2 2021.
Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2021) Analysis & Trends
Insight Molecular Diagnostics has disclosed Tax Provisions across 2 years of filings, most recently posting -$97000.0 for Q4 2021.
- Tax Provisions for Q4 2021 came in at -$97000.0, down 161.01% year-over-year; the trailing twelve-month figure through Sep 2024 was -$97000.0 (changed N/A YoY), and the FY2022 annual result was -$8.1 million, up 12.9% from the prior year.
- Tax Provisions came in at -$97000.0 for Q4 2021 at Insight Molecular Diagnostics, up from -$1.8 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $1.1 million in Q1 2020 to a low of -$7.6 million in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -16.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 70.00 Mn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 206.00 Mn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 77.00 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 69.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 59.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 300,000.00 |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 23.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 40.20 Mn |
| 10 | Insight Molecular Diagnostics | 4.34 Mn | -24.59 Mn | 15,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -97,000.00 |
| Jun 30, 2021 | -1.79 Mn |
| Mar 31, 2021 | -7.56 Mn |
| Dec 31, 2020 | 159,000.00 |
| Jun 30, 2020 | -2.19 Mn |
| Mar 31, 2020 | 1.10 Mn |